Share
Graham Phillips
Endologix LLC, a privately held global medical device company dedicated to innovative therapies for vascular disease, is pleased to announce the appointment of Graham Phillips as its new Chief Operating Officer.
Phillips joins Endologix after a distinguished 18-year tenure with Medtronic, Covidien, and Tyco Healthcare, where he most recently served as Vice President of Manufacturing for the Americas East Region. In this role, he managed a large global team across 25 manufacturing sites spanning Canada to Brazil, the Caribbean, the Midwest, and the U.S. East Coast. His leadership was pivotal in shaping Medtronic’s operational success, contributing significantly to various portfolios servicing all operating units. Prior to his work in medical devices, Phillips held key manufacturing management roles at Budelpack and Kraft Foods.
Phillips holds an undergraduate degree in Mechanical Engineering from the University of Teesside, UK, an MBA from the University of Warwick Business School, UK, and an Advanced Management qualification from Chicago Booth Business School. He is also a Chartered Engineer with the UK Institute of Mechanical Engineers and a Six Sigma Black Belt, reflecting his dedication to operational excellence and manufacturing efficiency.
In his role as COO at Endologix, Phillips will oversee manufacturing, supply chain, R&D, and quality, and will be a key member of the executive leadership team, reporting directly to Matt Thompson, MD, President, and CEO of Endologix.
Matt Thompson commented, “I am thrilled to welcome Graham to Endologix. His proven leadership and extensive operational expertise will be critical as we continue to drive growth and innovation within our company.”
Regarding his new appointment, Graham Phillips said, “Joining Endologix is a tremendous opportunity to apply my extensive background in operational management to enhance our manufacturing and R&D processes. I am committed to optimizing our operations to support Endologix’s mission of delivering innovative healthcare solutions to improve the lives of patients with vascular disease.”
